SCHEMBL5857978

SCHEMBL5857978

NS(=O)(=O)c1ccc(N2N=C(c3ccccc3OC(F)(F)F)CC2c2cccc(F)c2F)cc1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 10/20 0.56
▸ CA1 P00915 7/20 0.56
▸ ACHE P22303 6/20 0.56
▸ MMP2 P08253 5/20 0.55
▸ MMP9 P14780 5/20 0.55
▸ L3MBTL1 Q9Y468 4/20 0.54
▸ PTGS1 P23219 1/20 0.48
▸ PTGS2 P35354 1/20 0.48
▸ KDM4E B2RXH2 1/20 0.48
▸ ALDH1A1 P00352 1/20 0.48
▸ LMNA P02545 1/20 0.48
▸ GLA P06280 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ HPGD P15428 1/20 0.48
▸ ATM Q13315 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6228483 0.78 PTGS1 (0.72) PTGS1PTGS2
SCHEMBL5856805 0.72 PTGS1 (0.74) PTGS1PTGS2
SCHEMBL5856591 0.71 PTGS1 (0.67) PTGS1PTGS2
SCHEMBL27954382 0.70 MMP2 (0.77) CA2CA1MMP2MMP9L3MBTL1
SCHEMBL27991879 0.69 MMP2 (1.00) MMP2MMP9L3MBTL1PTGS1PTGS2
SCHEMBL18826385 0.69 L3MBTL1 (0.80) CA2CA1ACHEMMP2MMP9
SCHEMBL1069328 0.69 DRD1 (0.64) CA2CA1PTGS1PTGS2
SCHEMBL5856582 0.69 PTGS1 (0.69) PTGS1PTGS2
SCHEMBL27991839 0.68 MMP2 (0.75) CA2CA1MMP2MMP9L3MBTL1
SCHEMBL28810693 0.67 L3MBTL1 (0.79) CA2CA1ACHEMMP2MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE38963-E1 Pyrazoline derivatives, their preparation and application as medicaments LABORATORIOS DEL DR. ESTEVE (ES) 2006-01-31 — — US claimed
US-6353117-B1 ANTIINFLAMMATORY ACTIVITY AND DISEASES IN WHICH CYCLOOXYGENASE-2 PLAYS A PART, WITHOUT HAVING THE GASTRIC AND RENAL TOXICITY OF THE CLASSIC NONSTEROIDAL ANTIINFLAMMATORY AGENTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2002-03-05 — — US claimed
Send feedback